2000

 

 

  • The FDA approves Botox® (onabotulinumtoxinA) manufactured by Allergan, for the treatment of abnormal head position and neck pain associated with cervical dystonia.
  • The FDA also approves Myobloc® (rimabotulinumtoxinB) for the same indication.
  • Myobloc is the US trade name for BoNT-B from Elan Pharmaceuticals (Neurobloc® in Europe).